News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProMetic Life Sciences Inc. (PFSCF.PK) to Obtain Controlling Stake in Pathogen Removal and Diagnostic Technologies Inc.


4/9/2008 10:52:21 AM

MONTREAL, QC and CAMBRIDGE, ENGLAND--(Marketwire - April 09, 2008) - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces that ProMetic has signed a Letter of Intent ("LOI") to acquire the American Red Cross' ("ARC") common stock holding in Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), the joint venture established by ProMetic and ARC in 2002 to develop and commercialize products to diagnose and reduce pathogens in blood, blood derivatives, biopharmaceuticals and other biological products.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES